Progressive Multifocal Leukoencephalopathy: Epidemiology, Clinical Manifestations, and Diagnosis
www.UptoDate.com, May, Koralnik, I.J., 2018
A Fatal Case of JC Virus Meningitis Presenting with Hydrocephalus in a Human Immunodeficiency Virus-Seronegative Patient
Ann Neurol 76:140-147, Agnihotri, S.P.,et al, 2014
Diagnosis of AIDS-Related Focal Brain Lesions
Neurol 48:687-694, Antinori,A.,et al, 1997
Natalizumab-Associated PML
Neurol 88:1197-1205, Schwab, N.,et al, 2017
Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
NEJM 366:1870-1880,1938, Bloomgren, G.,et al, 2012
Natalizumab and Progressive Multifocal Leukoencephalopathy: What are the Causal Factors and Can It be Avoided?
Arch Neurol 67:923-930, Warnke,C., et al, 2010
Progressive Multifocal Leukoencephalopathy: Can We Reduce Risk in Patients Receiving Biological Immunomodulatory Therapies?
Ann Neurol 68:271-274, Tyler,K., 2010
Opportunistic Infections and Other Risks with Newer Multiple Sclerosis Therapies
Ann Neurol 65:367-377, Berger,J.R. &Houff,S., 2009
Progressive Multifocal Leukoencephalopathy Complicating Treatment with Natalizumab and Interferon Beta-1a for Multiple Sclerosis
NEJM 353:369-374,414,432, Kleinschemidt-DeMasters,B.K. &Tyler,K.L., 2005
JC Virus DNA in CSF of HIV-Infected Pts:Predictive Value for Progressive Multifocal Leukoencephalopathy
Ann Neurol 37:395-399, McGuire,D.,et al, 1995
Detection of JC Virus DNA in Peripherl Lymphocytes from PTs with & Without Progressive Multifocal Leukoencephalopathy
Ann Neurol 31:454-462, Tornatore,C.,et al, 1992